Seguir
David Harold Drewry
David Harold Drewry
Dirección de correo verificada de unc.edu
Título
Citado por
Citado por
Año
Structure of the catalytic domain of fibroblast collagenase complexed with an inhibitor
B Lovejoy, A Cleasby, AM Hassell, K Longley, MA Luther, D Weigl, ...
Science 263 (5145), 375-377, 1994
4231994
Comprehensive characterization of the published kinase inhibitor set
JM Elkins, V Fedele, M Szklarz, KR Abdul Azeez, E Salah, J Mikolajczyk, ...
Nature biotechnology 34 (1), 95-103, 2016
3482016
New compound sets identified from high throughput phenotypic screening against three kinetoplastid parasites: an open resource
I Pena, M Pilar Manzano, J Cantizani, A Kessler, J Alonso-Padilla, ...
Scientific reports 5 (1), 8771, 2015
2762015
Discovery of I-BRD9, a selective cell active chemical probe for bromodomain containing protein 9 inhibition
NH Theodoulou, P Bamborough, AJ Bannister, I Becher, RA Bit, KH Che, ...
Journal of medicinal chemistry 59 (4), 1425-1439, 2016
2342016
Quantitative, wide-spectrum kinase profiling in live cells for assessing the effect of cellular ATP on target engagement
JD Vasta, CR Corona, J Wilkinson, CA Zimprich, JR Hartnett, MR Ingold, ...
Cell chemical biology 25 (2), 206-214. e11, 2018
2212018
Solid‐supported reagents in organic synthesis
DH Drewry, DM Coe, S Poon
Medicinal research reviews 19 (2), 97-148, 1999
2161999
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery
P Bamborough, D Drewry, G Harper, GK Smith, K Schneider
Journal of medicinal chemistry 51 (24), 7898-7914, 2008
2042008
A public-private partnership to unlock the untargeted kinome
S Knapp, P Arruda, J Blagg, S Burley, DH Drewry, A Edwards, D Fabbro, ...
Nature chemical biology 9 (1), 3-6, 2013
1732013
Enhancements of screening collections to address areas of unmet medical need: an industry perspective
DH Drewry, R Macarron
Current opinion in chemical biology 14 (3), 289-298, 2010
1652010
Discovery and characterization of GSK2801, a selective chemical probe for the bromodomains BAZ2A and BAZ2B
P Chen, A Chaikuad, P Bamborough, M Bantscheff, C Bountra, C Chung, ...
Journal of medicinal chemistry 59 (4), 1410-1424, 2016
1602016
Progress towards a public chemogenomic set for protein kinases and a call for contributions
DH Drewry, CI Wells, DM Andrews, R Angell, H Al-Ali, AD Axtman, ...
PloS one 12 (8), e0181585, 2017
1572017
Discovery of GSK1070916, a potent and selective inhibitor of Aurora B/C kinase
ND Adams, JL Adams, JL Burgess, AM Chaudhari, RA Copeland, ...
Journal of medicinal chemistry 53 (10), 3973-4001, 2010
1292010
Seeding collaborations to advance kinase science with the GSK Published Kinase Inhibitor Set (PKIS)
D H Drewry, T M Willson, W J Zuercher
Current topics in medicinal chemistry 14 (3), 340-342, 2014
1272014
Plasmodium Kinases As Targets For New-Generation Antimalarials
IS Lucet, A Tobin, D Drewry, AF Wilks, C Doerig
Future medicinal chemistry 4 (18), 2295-2310, 2012
1022012
Donated chemical probes for open science
S Müller, S Ackloo, CH Arrowsmith, M Bauser, JL Baryza, J Blagg, ...
elife 7, e34311, 2018
972018
Solid-phase synthesis of trisubstituted guanidines
DH Drewry, SW Gerritz, JA Linn
Tetrahedron letters 38 (19), 3377-3380, 1997
971997
CaMKK2 in myeloid cells is a key regulator of the immune-suppressive microenvironment in breast cancer
L Racioppi, ER Nelson, W Huang, D Mukherjee, SA Lawrence, W Lento, ...
Nature Communications 10 (1), 2450, 2019
922019
Quantifying CDK inhibitor selectivity in live cells
CI Wells, JD Vasta, CR Corona, J Wilkinson, CA Zimprich, MR Ingold, ...
Nature communications 11 (1), 2743, 2020
892020
EGFR inhibitors identified as a potential treatment for chordoma in a focused compound screen
S Scheipl, M Barnard, L Cottone, M Jorgensen, DH Drewry, WJ Zuercher, ...
The Journal of pathology 239 (3), 320-334, 2016
842016
The kinase chemogenomic set (KCGS): an open science resource for kinase vulnerability identification
CI Wells, H Al-Ali, DM Andrews, CRM Asquith, AD Axtman, I Dikic, ...
International journal of molecular sciences 22 (2), 566, 2021
832021
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20